Koyfin Home > Directory > Health Care > Amicus Therapeutics > Levered Free Cash Flow (FCF)

Amicus Therapeutics Levered Free Cash Flow (FCF) Chart (FOLD)

Amicus Therapeutics annual/quarterly Levered Free Cash Flow (FCF) from 2007 to 2018.
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-78m a 35.32% decrease of -28m year over year
  • Amicus Therapeutics Levered Free Cash Flow (FCF) for the last 12 months ending September 09, 2018 was $-199m a 9.89% decrease of -20m year over year
  • Amicus Therapeutics Annual Levered Free Cash Flow (FCF) for 2017 was $-180m a 62.12% decrease of -112m from 2016
  • Amicus Therapeutics Annual Levered Free Cash Flow (FCF) for 2016 was $-68m a 77.71% decrease of -53m from 2015
  • Amicus Therapeutics Annual Levered Free Cash Flow (FCF) for 2015 was $-15m a -77.75% increase of 12m from 2014
Other Cash Flow Metrics:
  • Amicus Therapeutics Cash Flow from Operations for the quarter ending September 09, 2018 was $-133m a 44.44% decrease of -59m year over year
  • Amicus Therapeutics Total Revenue for the quarter ending September 09, 2018 was $21m a 28.49% increase of 6m year over year
View Chart On Koyfin

Quarterly FOLD Levered Free Cash Flow (FCF) Data

09/2018$-78m
06/2018$-119m
03/2018$48m
12/2017$-51m
09/2017$-67m
06/2017$-31m
03/2017$-32m
12/2016$-7m
09/2016$-22m
06/2016$-6m

Annual FOLD Levered Free Cash Flow (FCF) Data

2017$-180m
2016$-68m
2015$-15m
2014$-27m
2013$-31m
2012$-33m
2011$-28m
2010$-22m
2009$2m
2008$-25m